Gene Query: PRLR

Dataset Description Geneva Score
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 91.38
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 91.38
Silencing p300 in MCF7 cells to study expression and alternative splicing 88.37
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 83.23
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 63.74
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 60.32
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 58.26
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 56.24
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 53.08
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 48.84
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 48.84
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 48.46
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 44.64
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 42.63
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 41.58
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 41.56
Primary human trophoblast from term placenta 36.3
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 35.89
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 35.59
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 34.85
Differential Gene Expression between MCF10A and MCF7 cells 33.65
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 33.5
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 33.37
Genome wide expression change in LCC2 and MCF-7 cells 32.97
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 32.34
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 32.34
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 31.49
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 31.49
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 30.35
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 30.35
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 30.25
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 29.69
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 29.69
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 28.05
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 27.69
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 26.62
Gene expression profile in breast cancer cell lines using RNA sequencing 25.73
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 25.42
An RNA-centric dissection of host complexes controlling flavivirus infection 25.42
RNA-Seq of the corpus callosum from 12 individuals 25.01
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 24.84
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 24.84
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 24.34
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 23.86
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 23.77
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 23.02
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 21.62
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 21.62
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 21.0
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 20.49
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 19.97
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 19.8
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 19.8
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 19.67
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 19.28
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 19.18
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 19.03
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 18.34
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 18.26
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 17.84
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 17.48
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 17.22
EP400 is required for Max and MCPyV mediated gene activation 17.2
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 16.41
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 16.37
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 16.1
Fusion discovery in breast cancer cell line 15.8
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 15.76
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 15.68
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 15.61
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 15.23
RNA-Seq analysis of breast cancer cells after shikonin treatment 15.18
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 15.12
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 15.04
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 15.04
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 14.95
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 14.91
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 14.73
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 14.24
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 14.11
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 14.11
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 13.92
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 13.51
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 13.51
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 13.2
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 13.19
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 13.11
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 13.09
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 13.06
Conservative alteration of chromosomal expression pattern across human solid tumor types 12.97
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 12.87
Depicting early human development and germ cell origin with porcine embryos 12.87
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 12.63
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 12.5
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 12.09
Epigenome regulation during epidermal lineage commitment [RNA-seq] 12.07
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 12.07
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 11.85
Gene expression profile difference among renal location in a stone former 11.73
Effects of rFVIIIFc on human macrophages 11.57
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 11.4
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 11.29
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 11.27
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 11.2
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 11.06
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 10.65
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 10.51
A role for ZNF598 in post-transcriptional gene regulation 10.49
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 10.47
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 10.29
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 10.21
PGE2 mediated gene expression changes in human cervical stromal cells 10.11
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 10.08
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 10.04
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 9.99
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 9.79
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 9.72
Global analyses of the effect of different cellular contexts on microRNA targeting 9.69
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 9.69
Endometrial transcriptome and PGR cistrome in cycling fertile women 9.63
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 9.63
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 9.59
BASP1 modifies the Tamoxifen response 9.3
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 9.2
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 9.14
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 9.07
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 9.07
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 9.0
Chromatin-informed inference of transcriptional programs in gynecologic cancers 9.0
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 9.0
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 9.0
Genome wide expression change by RNF168 knocking down in MCF-7 cells 8.96
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 8.92
A prostate cancer chromatin interaction map 8.85
Expression profiling of MCF-7 cells with treatment of TCDD 8.84
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 8.84
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 8.73
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 8.73
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 8.65
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 8.49
RNA-seq in endometrial stromal tumors 8.48
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 8.44
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 8.39
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 8.39
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 8.38
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 8.38
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 8.36
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 8.21
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 8.21
Human ovarian granulosa cell transcriptome 8.16
RNA-seq analyses of human prostate cancer cells 8.1
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 7.93
RNA-sequencing of human liver tissue 7.85
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 7.82
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 7.82
Small-molecule targeting of brachyury transcription factor addiction in chordoma 7.79
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 7.62
Ro60-knockout cells 7.61
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 7.49
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 7.31
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 7.31
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 7.3
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 7.3
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 7.08
snRNAs as regulators of alternative splicing 7.07
RNA-sequencing 7.06
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 7.05
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 6.96
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 6.96
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 6.93
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 6.93
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.83
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 6.82
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 6.72
The transcriptome effect of overexpressing EZH2 in MCF7 6.63
Changes in human endometrial gland transcriptome over the window of implantation 6.43
Epigenome regulation during epidermal lineage commitment 6.41
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 6.36
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 6.25
Persistence of stem cell metabolism in cancers as a failure of differentiation 6.24
RNAseq of cell lines with knocked in ESR1 mutations 6.17
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 6.15
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 6.05
Gene profiling of human adult and pediatric liver cancer cells 6.01
NKX2.2 5.75
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 5.75
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 5.7
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 5.62
Active translatome profiling with RiboLace in MCF7 cells 5.59
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 5.58
Differences in miRNA Detection Levels are Technology and Sequence Dependent 5.58
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 5.58
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 5.57
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 5.55
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 5.42
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 5.41
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 5.41
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 5.36
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 5.33
Transcriptome analysis of BAP1 knockout and restoration 5.26
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 5.26
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 5.25
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 5.25
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 5.13
Cerebellar differentiation in Ataxia-Telangiectasia 5.08
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 5.05
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 5.04
iPSC-Derived Cholangiocytes 5.01
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 4.93
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 4.93
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 4.89
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 4.87
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 4.78
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 4.77
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 4.72
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.61
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.61
RNA-seq analysis of breast cancer 4.6
RNA-seq analysis and shRNA screen of breast cancer 4.6
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 4.57
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 4.57
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 4.56
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 4.53
Global transcriptome analysis of HAP1 cells 4.5
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 4.49
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 4.46
RNA-seq of cancer cell lines treated with T-025 4.35
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 4.33
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 4.31
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 4.28
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 4.27
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 4.27
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 4.26
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 4.2
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 4.16
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.09
m6A-dependent regulation of messenger RNA stability 4.02
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 3.95
Retinoic acid suppresses MYB in adenoid cystic carcinoma 3.95
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 3.95
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 3.93
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 3.88
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 3.88
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 3.88
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 3.88
Genome-wide identification of cancer-specific alternative splicing in circRNA 3.88
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 3.86
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 3.83
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 3.83
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 3.81
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 3.81
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 3.81
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 3.69
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 3.68
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 3.67
Gene expression analysis of human liver progenitor-like cells in culture 3.67
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 3.66
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 3.65
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 3.58
Gene expression analysis of human hepatocellular cancers 3.51
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 3.51
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 3.5
NR2F2 study 3.42
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 3.42
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.37
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 3.37
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 3.36
Expression profiles of the four human major ectodermal lineages 3.36
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 3.33
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 3.33
RNAseq of Breast cancer PDX samples 3.32
Transcriptomic analysis of LSD1 3.3
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.29
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 3.28
Loss of endometrial plasticity in recurrent pregnancy loss 3.27
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 3.27
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 3.21
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 3.19
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 3.19
3.17
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 3.15
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 3.14
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 3.11
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.04
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.03
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 3.03
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 3.0
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 2.96
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 2.94
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 2.94
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 2.91
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.84
BI Human Reference Epigenome Mapping Project 2.83
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 2.82
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 2.81
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.8
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 2.78
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.77
Gene expression analysis of dengue-infected cells 2.76
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 2.74
MCF-7 as a model for functional analysis of breast cancer risk variants 2.72
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 2.67
Differential Protein Occupancy Profiling of the mRNA Transcriptome 2.64
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 2.62
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 2.62
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 2.6
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 2.57
Total RNA sequencing of APC mutant and wt colonic organoids 2.55
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 2.54
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 2.53
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 2.52
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.49
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 2.48
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 2.47
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 2.47
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 2.46
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 2.43
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 2.4
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.38
RNA-seq differential expression studies: more sequence, or more replication? 2.37
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 2.37
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 2.36
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 2.36
T47D RNA-seq and ChrRNA-seq data 2.36
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 2.33
The pioneer factor CEBPA modulates vitamin D signaling 2.33
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 2.32
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 2.31
Gene expression of collecting duct carcinoma of the kidney 2.31
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 2.28
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 2.23
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 2.21
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 2.21
Common inflammatory pathways between NEC and Crohn's disease 2.18
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.17
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.17
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 2.16
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.14
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 2.1
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 2.1
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 2.09
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 2.08
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 2.07
STX4 Over-Expression in Human islets 2.07
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 2.05
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 2.03
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 1.99
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 1.99
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.98
Transcriptome analysis of virus infected tissues 1.96
The role of CFTR in islet function 1.93
Illumina HiSeq Sequencing on Breast cancer PDX samples 1.92
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 1.83
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.82
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 1.82
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 1.78
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.78
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 1.77
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 1.76
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.76
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 1.74
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 1.74
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.72
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.72
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.69
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.69
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 1.66
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 1.66
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.53
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.52
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 1.52
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 1.51
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.51
Molecular analysis of renal cell carcinoma with unclassfied histology 1.5
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.5
Interaction between mitoNEET and NAF-1 in cancer cells 1.43
mRNA-sequencing of breast cancer subtypes and normal tissue 1.39
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.36
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 1.35
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 1.28
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 1.27
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.26
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 1.25
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.24
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.22
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.22
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.22
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.21
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 1.2
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 1.19
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.18
Human islets of varying quality: the good, the (not so) bad and the ugly 1.14
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.14
In vitro modeling of human germ cell development using pluripotent stem cells 1.12
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 1.1
Microprocessor mediates transcription termination in long noncoding microRNA genes 1.1
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 1.06
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 1.05
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.03
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.03
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 1.01
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 1.01
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.01
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.98
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.92
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.92
Comparing gene expression in iPSC derived RPE from control and AMD donors 0.91
Evaluating pre-clinical models for studying NASH driven HCC. 0.9
RNA sequencing of matched nephrectomy samples [RNA-seq] 0.89
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 0.89
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.85
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.85
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.8
Multiple sclerosis and EAE 0.79
Human optic chiasm from healthy controls and multiple sclerosis patients 0.79
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 0.78
Nonpregnant and term pregnant human myometrial tissues 0.78
MHC Transcriptomic landscape at haplotype-specific resolution 0.77
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.77
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.77
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.76
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.74
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.72
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 0.71
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 0.7
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 0.7
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.7
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.69
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.65
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 0.64
ML29755 RNA-seq data 0.63
Interphase condensins regulate ligand-depedent enhancer activation 0.61
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.61
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.58
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.58
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 0.58
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 0.58
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 0.58
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.57
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.56
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.54
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.53
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.53
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.53
RNA-Seq with and without RNase treatment in PCa cell lines 0.52
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.51
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.49
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.46
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.46
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 0.46
Hepatitis C virus functionally sequesters miR-122 0.46
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 0.45
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.45
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.43
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.43
RNAseq analysis of ruxolitinib treated breast cancers 0.42
RNA-seq analysis of the human fetal kidney. 0.41
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 0.4
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.39
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.39
Preclinical model of obesity and ER-positive breast cancer 0.39
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.39
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.38
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.38
RNA Seq of Alagille liver biopsies 0.36
Alagille_Nodder 0.36
RNA-seq of primary patient AML samples 0.35
mRNA-Seq profiling of human developing kidney 0.35
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 0.34
Specific molecular signatures underlie response to decitabine in CMML 0.34
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.34
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 0.33
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 0.33
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.33
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.31
The gene expression profiles of gallbladder cancer 0.3
MicroRNA-125a-5p overexpression in human macrophages 0.28
Transcriptome Profiling of Human Primary Monocytes 0.28
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.27
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.26
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.26
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.26
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.25
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.25
Regulation of hypoxia-inducible factor activity by ZMYND8 0.21
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.2
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.2
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.19
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.18
A practical evaluation of alignment algorithms for RNA variant calling analysis 0.18
Identification of expressed and conserved human non-coding RNAs 0.17
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.17
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.15
Gene expression analysis of breast cancer cell-lines 0.1
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.1
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.08
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.07
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.05
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.04
Gene expression of thyroid cancer cell lines 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation